SIGLEC15 and melanoma: Considering that CYTL1 may be a potential oncogene in melanoma, it was assessed how CYTL1 interacted with PDCD1, CD274, HAVCR2, TIGIT, SIGLEC15, CTLA4, LAG3, and PDCD1LG2.